Breaking News

Gilead Breaks Ground on Pharmaceutical Development & Manufacturing Technical Development Center

The milestone is part of Gilead’s planned $32 billion investment in U.S. innovation through 2030.

Author Image

By: Charlie Sternberg

Associate Editor

Gilead Sciences has broken ground on its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC) at the company’s Foster City headquarters. This milestone is part of Gilead’s planned $32 billion investment in U.S. innovation through 2030. This investment is projected to generate more than $43 billion in economic value nationwide, strengthening America’s biopharmaceutical leadership while fueling jobs, research, and domestic manufacturing. “This new facili...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters